INS and Hyperglycemia: When there are variations on meal sizes or insulin sensitivity, both insulin-only and prediction/suspending therapies are faced with increased hypoglycemia and hyperglycemia events; however, both P-type and PD-type therapies can keep all glucose concentrations within the safe range (70~180 mg/dL).